发明公开
- 专利标题： NOVEL ADENINE COMPOUND
- 专利标题（中）： 新的腺嘌呤化合物
-
申请号： EP08738681.9申请日： 2008-03-19
-
公开(公告)号： EP2138497A1公开(公告)日： 2009-12-30
- 发明人: ISOBE, Yoshiaki , NAKAMURA, Tomoaki
- 申请人： Dainippon Sumitomo Pharma Co., Ltd. , AstraZeneca AB
- 申请人地址： 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi Osaka 541-8524 JP
- 专利权人： Dainippon Sumitomo Pharma Co., Ltd.,AstraZeneca AB
- 当前专利权人： Dainippon Sumitomo Pharma Co., Ltd.,AstraZeneca AB
- 当前专利权人地址： 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi Osaka 541-8524 JP
- 代理机构： Vossius & Partner
- 优先权： JP2007071711 20070320
- 国际公布： WO2008114819 20080925
- 主分类号： C07D473/34
- IPC分类号： C07D473/34 ; A61K31/522 ; A61P1/04 ; A61P3/10 ; A61P5/14 ; A61P7/02 ; A61P7/10 ; A61P9/12 ; A61P9/14 ; A61P11/00 ; A61P11/02 ; A61P11/04 ; A61P11/06 ; A61P11/08 ; A61P11/16 ; A61P13/02 ; A61P13/08 ; A61P13/10 ; A61P13/12 ; A61P15/00 ; A61P15/02
摘要：
A novel adenine compound represented by the formula (1):
[wherein R 1 is substituted or unsubstituted alkyl, etc., X is oxygen, etc., A 1 is 4- to 8-membered substituted or unsubstituted saturated nitrogen-containing heterocycle containing 1 to 2 hetero atom(s) selected from 1 to 2 nitrogen(s), 0 to 1 oxygen and 0 to 1 sulfur, etc., A 2 is substituted or unsubstituted 6- to 10-membered aryl, etc., L 1 and L 2 are independently a straight chain or branched chain alkylene, etc.], or a pharmaceutically acceptable salt thereof, which is useful as a medicament.
[wherein R 1 is substituted or unsubstituted alkyl, etc., X is oxygen, etc., A 1 is 4- to 8-membered substituted or unsubstituted saturated nitrogen-containing heterocycle containing 1 to 2 hetero atom(s) selected from 1 to 2 nitrogen(s), 0 to 1 oxygen and 0 to 1 sulfur, etc., A 2 is substituted or unsubstituted 6- to 10-membered aryl, etc., L 1 and L 2 are independently a straight chain or branched chain alkylene, etc.], or a pharmaceutically acceptable salt thereof, which is useful as a medicament.
信息查询
